152 related articles for article (PubMed ID: 23863947)
21. Motor, emotional and cognitive deficits in adult BACHD mice: a model for Huntington's disease.
Abada YS; Schreiber R; Ellenbroek B
Behav Brain Res; 2013 Feb; 238():243-51. PubMed ID: 23123142
[TBL] [Abstract][Full Text] [Related]
22. Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington's disease.
Heikkinen T; Bragge T; Bhattarai N; Parkkari T; Puoliväli J; Kontkanen O; Sweeney P; Park LC; Munoz-Sanjuan I
PLoS One; 2020; 15(12):e0243052. PubMed ID: 33370315
[TBL] [Abstract][Full Text] [Related]
23. Changes in structure and function of diaphragm neuromuscular junctions from BACHD mouse model for Huntington's disease.
de Aragão BC; Rodrigues HA; Valadão PA; Camargo W; Naves LA; Ribeiro FM; Guatimosim C
Neurochem Int; 2016 Feb; 93():64-72. PubMed ID: 26796203
[TBL] [Abstract][Full Text] [Related]
24. Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.
Wood TE; Barry J; Yang Z; Cepeda C; Levine MS; Gray M
Hum Mol Genet; 2019 Feb; 28(3):487-500. PubMed ID: 30312396
[TBL] [Abstract][Full Text] [Related]
25. The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function.
Pallier PN; Drew CJ; Morton AJ
Brain Res Bull; 2009 Mar; 78(6):347-55. PubMed ID: 19010400
[TBL] [Abstract][Full Text] [Related]
26. Degeneration of ipRGCs in Mouse Models of Huntington's Disease Disrupts Non-Image-Forming Behaviors Before Motor Impairment.
Lin MS; Liao PY; Chen HM; Chang CP; Chen SK; Chern Y
J Neurosci; 2019 Feb; 39(8):1505-1524. PubMed ID: 30587542
[TBL] [Abstract][Full Text] [Related]
27. Abnormal Photic Entrainment to Phase-Delaying Stimuli in the R6/2 Mouse Model of Huntington's Disease, despite Retinal Responsiveness to Light.
Ouk K; Aungier J; Ware M; Morton AJ
eNeuro; 2019; 6(6):. PubMed ID: 31744839
[TBL] [Abstract][Full Text] [Related]
28. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
[TBL] [Abstract][Full Text] [Related]
29. Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease.
Dufour BD; McBride JL
Exp Neurol; 2016 Sep; 283(Pt A):308-17. PubMed ID: 27381424
[TBL] [Abstract][Full Text] [Related]
30. Baroreceptor reflex dysfunction in the BACHD mouse model of Huntington's disease.
Schroeder AM; Loh DH; Jordan MC; Roos KP; Colwell CS
PLoS Curr; 2011 Nov; 3():RRN1266. PubMed ID: 22069044
[TBL] [Abstract][Full Text] [Related]
31. Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.
Spires TL; Grote HE; Garry S; Cordery PM; Van Dellen A; Blakemore C; Hannan AJ
Eur J Neurosci; 2004 May; 19(10):2799-807. PubMed ID: 15147313
[TBL] [Abstract][Full Text] [Related]
32. Striatal pre-enkephalin overexpression improves Huntington's disease symptoms in the R6/2 mouse model of Huntington's disease.
Bissonnette S; Vaillancourt M; Hébert SS; Drolet G; Samadi P
PLoS One; 2013; 8(9):e75099. PubMed ID: 24040390
[TBL] [Abstract][Full Text] [Related]
33. Relationship between subthalamic nucleus neuronal activity and electrocorticogram is altered in the R6/2 mouse model of Huntington's disease.
Callahan JW; Abercrombie ED
J Physiol; 2015 Aug; 593(16):3727-38. PubMed ID: 25952461
[TBL] [Abstract][Full Text] [Related]
34. Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease.
van Dellen A; Cordery PM; Spires TL; Blakemore C; Hannan AJ
BMC Neurosci; 2008 Apr; 9():34. PubMed ID: 18380890
[TBL] [Abstract][Full Text] [Related]
35. Ghrelin-mediated improvements in the metabolic phenotype in the R6/2 mouse model of Huntington's disease.
Rudenko O; Springer C; Skov LJ; Madsen AN; Hasholt L; Nørremølle A; Holst B
J Neuroendocrinol; 2019 Jul; 31(7):e12699. PubMed ID: 30776164
[TBL] [Abstract][Full Text] [Related]
36. Lack of anticipatory behavior in Gpr88 knockout mice showed by automatized home cage phenotyping.
Maroteaux G; Arefin TM; Harsan LA; Darcq E; Ben Hamida S; Kieffer BL
Genes Brain Behav; 2018 Nov; 17(8):e12473. PubMed ID: 29575471
[TBL] [Abstract][Full Text] [Related]
37. Analysis of Individual Mouse Activity in Group Housed Animals of Different Inbred Strains using a Novel Automated Home Cage Analysis System.
Bains RS; Cater HL; Sillito RR; Chartsias A; Sneddon D; Concas D; Keskivali-Bond P; Lukins TC; Wells S; Acevedo Arozena A; Nolan PM; Armstrong JD
Front Behav Neurosci; 2016; 10():106. PubMed ID: 27375446
[TBL] [Abstract][Full Text] [Related]
38. Exercise training normalizes mitochondrial respiratory capacity within the striatum of the R6/1 model of Huntington's disease.
Herbst EA; Holloway GP
Neuroscience; 2015 Sep; 303():515-23. PubMed ID: 26186895
[TBL] [Abstract][Full Text] [Related]
39. Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease.
Estrada-Sánchez AM; Burroughs CL; Cavaliere S; Barton SJ; Chen S; Yang XW; Rebec GV
J Neurosci; 2015 Mar; 35(10):4440-51. PubMed ID: 25762686
[TBL] [Abstract][Full Text] [Related]
40. Cognitive training modifies disease symptoms in a mouse model of Huntington's disease.
Yhnell E; Lelos MJ; Dunnett SB; Brooks SP
Exp Neurol; 2016 Aug; 282():19-26. PubMed ID: 27163546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
